The contribution of rare germline variants to the immune landscape of breast cancer.

IF 10.4 1区 生物学 Q1 GENETICS & HEREDITY
Felipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, Aaron J Bernstein, Amber N Hurson, Thomas U Ahearn, Irene L Andrulis, Antonis C Antoniou, Sabine Behrens, Katarzyna Białkowska, Fiona M Blows, Manjeet K Bolla, Nicola J Camp, Melissa H Cessna, Jenny Chang-Claude, Stephen J Chanock, Joe Dennis, Peter Devilee, Alison M Dunning, Jacek Gronwald, Ute Hamann, Antoinette Hollestelle, Maartje J Hooning, Hugo M Horlings, Agnes Jager, Anna Jakubowska, Brandt Jones, Rudolf Kaaks, Marleen Kok, Jolanta Lissowska, Jan Lubiński, Mehdi Manoochehri, Jodi L Miller, Noor Muhammad, Anna Marie Mulligan, Nadia Obi, Muhammad U Rashid, Hans-Peter Sinn, Carolien H M van Deurzen, Qin Wang, Justin A Williams, Xiaohong R Yang, Douglas F Easton, H Raza Ali, Montserrat García-Closas, Paul D P Pharoah, Mustapha Abubakar, Marjanka K Schmidt
{"title":"The contribution of rare germline variants to the immune landscape of breast cancer.","authors":"Felipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, Aaron J Bernstein, Amber N Hurson, Thomas U Ahearn, Irene L Andrulis, Antonis C Antoniou, Sabine Behrens, Katarzyna Białkowska, Fiona M Blows, Manjeet K Bolla, Nicola J Camp, Melissa H Cessna, Jenny Chang-Claude, Stephen J Chanock, Joe Dennis, Peter Devilee, Alison M Dunning, Jacek Gronwald, Ute Hamann, Antoinette Hollestelle, Maartje J Hooning, Hugo M Horlings, Agnes Jager, Anna Jakubowska, Brandt Jones, Rudolf Kaaks, Marleen Kok, Jolanta Lissowska, Jan Lubiński, Mehdi Manoochehri, Jodi L Miller, Noor Muhammad, Anna Marie Mulligan, Nadia Obi, Muhammad U Rashid, Hans-Peter Sinn, Carolien H M van Deurzen, Qin Wang, Justin A Williams, Xiaohong R Yang, Douglas F Easton, H Raza Ali, Montserrat García-Closas, Paul D P Pharoah, Mustapha Abubakar, Marjanka K Schmidt","doi":"10.1186/s13073-026-01662-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many breast cancer predisposition genes are involved in DNA damage repair, leading to genome instability that can impact immunosurveillance, neoantigen formation, and the composition of the tumor immune microenvironment.</p><p><strong>Methods: </strong>Here, we explored associations between germline protein truncating variants (PTVs) in 34 (putative) breast cancer predisposition genes, of which 26 involved in DNA damage repair, with the abundance of four immune cell markers, i.e., CD8 + , FOXP3 + , CD20 + and CD163 + , across 7,969 invasive breast tumors of women of European ancestry.</p><p><strong>Results: </strong>The most apparent associations were those of CD163, a marker of M2-like tumor-associated macrophages, with genes involved in double- and single-strand break DNA repair, and with the 12 known breast cancer predisposition genes combined. Specifically, DNA damage repair genes, BRCA1, BRCA2, PALB2, RAD51D, and MSH6 were associated with a 1.3 to twofold abundance of CD163-positive cells. Estrogen receptor status was found to mediate associations to a limited extent.</p><p><strong>Conclusions: </strong>Our findings support a role of rare pathogenic germline variants involved in DNA damage repair, and particularly those predisposing to breast cancer, in the immune landscape of breast tumors. These insights may help guide the development of immunomodulatory strategies for breast cancer prevention and treatment.</p>","PeriodicalId":12645,"journal":{"name":"Genome Medicine","volume":" ","pages":""},"PeriodicalIF":10.4000,"publicationDate":"2026-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genome Medicine","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s13073-026-01662-6","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Many breast cancer predisposition genes are involved in DNA damage repair, leading to genome instability that can impact immunosurveillance, neoantigen formation, and the composition of the tumor immune microenvironment.

Methods: Here, we explored associations between germline protein truncating variants (PTVs) in 34 (putative) breast cancer predisposition genes, of which 26 involved in DNA damage repair, with the abundance of four immune cell markers, i.e., CD8 + , FOXP3 + , CD20 + and CD163 + , across 7,969 invasive breast tumors of women of European ancestry.

Results: The most apparent associations were those of CD163, a marker of M2-like tumor-associated macrophages, with genes involved in double- and single-strand break DNA repair, and with the 12 known breast cancer predisposition genes combined. Specifically, DNA damage repair genes, BRCA1, BRCA2, PALB2, RAD51D, and MSH6 were associated with a 1.3 to twofold abundance of CD163-positive cells. Estrogen receptor status was found to mediate associations to a limited extent.

Conclusions: Our findings support a role of rare pathogenic germline variants involved in DNA damage repair, and particularly those predisposing to breast cancer, in the immune landscape of breast tumors. These insights may help guide the development of immunomodulatory strategies for breast cancer prevention and treatment.

罕见种系变异对乳腺癌免疫景观的贡献。
背景:许多乳腺癌易感基因参与DNA损伤修复,导致基因组不稳定,从而影响免疫监视、新抗原形成和肿瘤免疫微环境的组成。方法:在这里,我们探索了34个(假定的)乳腺癌易感基因(其中26个参与DNA损伤修复)的种系蛋白截断变异体(PTVs)与四种免疫细胞标记物(CD8 +, FOXP3 +, CD20 +和CD163 +)的丰度之间的关系,这些免疫细胞标记物在7,969例欧洲血统女性的浸润性乳腺癌中。结果:最明显的相关性是CD163(一种m2样肿瘤相关巨噬细胞的标记物)与参与双链和单链断裂DNA修复的基因,以及与12种已知乳腺癌易感基因的结合。具体来说,DNA损伤修复基因BRCA1、BRCA2、PALB2、RAD51D和MSH6与cd163阳性细胞的1.3至2倍丰度相关。发现雌激素受体状态在有限程度上介导相关。结论:我们的研究结果支持罕见的致病种系变异参与DNA损伤修复的作用,特别是那些易患乳腺癌的种系变异,在乳腺肿瘤的免疫景观中。这些见解可能有助于指导乳腺癌预防和治疗的免疫调节策略的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Genome Medicine
Genome Medicine GENETICS & HEREDITY-
CiteScore
20.80
自引率
0.80%
发文量
128
审稿时长
6-12 weeks
期刊介绍: Genome Medicine is an open access journal that publishes outstanding research applying genetics, genomics, and multi-omics to understand, diagnose, and treat disease. Bridging basic science and clinical research, it covers areas such as cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The journal publishes original research, methods, software, and reviews to serve authors and promote broad interest and importance in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书